Bruush Oral Care Inc.
BRSHF
$0.0009
$0.000.00%
OTC PK
| 04/30/2023 | 01/31/2023 | 10/31/2022 | 07/31/2022 | ||
|---|---|---|---|---|---|
| Revenue | 7.78% | 26.07% | 32.08% | 41.56% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 7.78% | 26.07% | 32.08% | 41.56% | |
| Cost of Revenue | 111.14% | 50.23% | 570.94% | -40.93% | |
| Gross Profit | -45.17% | 13.06% | -13.68% | 141.07% | |
| SG&A Expenses | 62.44% | 72.85% | 201.61% | -24.63% | |
| Depreciation & Amortization | -60.71% | -60.71% | 58.14% | -3.33% | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 66.33% | 70.83% | 214.39% | -26.43% | |
| Operating Income | -85.37% | -84.90% | -289.03% | 43.97% | |
| Income Before Tax | 82.62% | 18.43% | 61.70% | 32.99% | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | 82.62% | 18.43% | 61.70% | 32.99% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | 82.62% | 18.43% | 61.70% | 32.99% | |
| EBIT | -85.37% | -84.90% | -289.03% | 43.97% | |
| EBITDA | -85.82% | -85.14% | -289.70% | 44.09% | |
| EPS Basic | 94.52% | 70.63% | 79.77% | 32.49% | |
| Normalized Basic EPS | 92.68% | 69.80% | 79.91% | 32.49% | |
| EPS Diluted | 94.52% | 70.63% | 79.77% | 32.49% | |
| Normalized Diluted EPS | 92.68% | 69.80% | 79.91% | 32.49% | |
| Average Basic Shares Outstanding | 217.24% | 177.67% | 89.26% | -0.76% | |
| Average Diluted Shares Outstanding | 217.24% | 177.67% | 89.26% | -0.76% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |